Everolimus in Anaplastic Thyroid Cancer: A Case Series

Background: Anaplastic thyroid cancer (ATC) is a very aggressive disease and accounts for over 50% of thyroid-cancer related deaths. mTOR inhibition has shown anti-tumor activity in ATC. We report our experience treating patients with ATC with everolimus off-protocol. Methods: Patients with confirme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Harris, Ethan J., Hanna, Glenn J., Chau, Nicole, Rabinowits, Guilherme, Haddad, Robert, Margalit, Danielle N., Schoenfeld, Jonathan, Tishler, Roy B., Barletta, Justine A., Nehs, Matthew, Janne, Pasi, Huang, Julian, Groden, Phillip, Kacew, Alec, Lorch, Jochen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6399130/
https://ncbi.nlm.nih.gov/pubmed/30863722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados